Pharmaceuticals

Personalized Cancer Vaccines Market Expected To Grow Steadily And Approach $20.52 Billion By 2030

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Personalized Cancer Vaccines Market Expected To Change From 2026 To 2030?

The personalized cancer vaccines market has demonstrated robust expansion over recent years. Projections indicate its size will increase from $256.65 billion in 2025 to $273.05 billion by 2026, advancing at a compound annual growth rate (CAGR) of 6.4%. Historically, this growth can be attributed to advances in cancer genomics, the unmet need in oncology treatments, limitations of traditional cancer therapies, the growth in immunotherapy research, and increased funding for cancer research.

The personalized cancer vaccines market size is anticipated to experience robust growth in the upcoming years. It is projected to expand to $350.3 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.4%. This expansion during the forecast period is attributable to the wider adoption of personalized medicine, rising cancer incidence rates, advancements in neoantigen discovery, increasing collaborations among biotech firms, and supportive regulatory frameworks. Prominent trends expected in this period encompass a growing emphasis on personalized immunotherapy, greater utilization of genomic tumor profiling, the expansion of therapeutic cancer vaccines, increasing integration with precision oncology, and heightened clinical trial activity in cancer vaccines.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19136&type=smp

Which Strong Drivers Are Impacting The Personalized Cancer Vaccines Market Growth?

The rising incidence of cancer is projected to fuel the expansion of the personalized cancer vaccine market moving forward. Cancer describes a range of illnesses characterized by uncontrolled cell division that can invade adjacent tissues and spread to other areas of the body. The increasing prevalence of cancer is influenced by factors such as aging populations, lifestyle modifications, environmental exposures, and improved diagnostic capabilities. The personalized cancer vaccine market aids cancer care by offering vaccines customized to patient-specific tumor antigens, thereby enhancing the immune system’s ability to detect and eliminate cancer cells. For instance, in July 2024, as per the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, cancer diagnoses in Australia increased from 160,570 cases in 2022 to 164,694 cases in 2023, showing a significant year-over-year rise. Therefore, the growing prevalence of cancer is a key driver for the personalized cancer vaccine market’s growth.

Which Segments Define The Personalized Cancer Vaccines Market Segment Structure?

The personalized cancer vaccines market covered in this report is segmented –

1) By Treatment Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma

3) By Mechanism Of Action: Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action

4) By Route Of Administration: Injectables, Other Routes Of Administration

5) By End Use: Hospitals, Clinic, Other End Users

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines, Combination Vaccines

2) By Therapeutic Cancer Vaccines: Dendritic Cell Vaccines, Peptide-Based Vaccines, DNA Vaccines, RNA Vaccines, Whole Cell Vaccines

Which Trends Are Influencing Demand In The Personalized Cancer Vaccines Market?

Leading companies in the personalized cancer vaccine market are concentrating on creating advanced therapeutic solutions. These solutions include personalized immunotherapy, which is designed to specifically target patient tumor mutations, aiming to improve treatment accuracy and clinical results. Personalized immunotherapy describes custom cancer treatments that utilize a patient’s unique genetic and tumor mutation profile, frequently administered through dendritic cell-based vaccines or neoantigen-targeted platforms, to stimulate a specific immune response against malignant cells. As an illustration, in August 2024, UCLA Health, a healthcare organization based in the US, initiated a groundbreaking clinical trial. This trial is assessing a personalized cancer vaccine that targets the H3 G34 mutation in diffuse hemispheric gliomas. It uses dendritic cells to activate immunity against RNA disruptions caused by this aggressive mutation, offering a promising treatment option for adolescents and young adults who typically face limited treatment choices and poor survival rates.

Who Are The Established Players Within The Personalized Cancer Vaccines Market?

Major companies operating in the personalized cancer vaccines market are Moderna Inc., CureVac AG, BioNTech SE, Genentech Inc., Merck & Co. Inc., GlaxoSmithKline plc, Achilles Therapeutics Plc, Evaxion Biotech AS, Geneos Therapeutics Inc., ISA Pharmaceuticals BV, VAXIMM GmbH, EpiVax Therapeutics Inc., Personalis Inc., Catalent Inc., Gritstone bio Inc., Neon Therapeutics Inc., Nouscom AG, Vaccitech plc, Agenus Inc., Transgene SA

Get The Full Personalized Cancer Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/personalized-cancer-vaccines-global-market-report

Where Is The Personalized Cancer Vaccines Market Most Concentrated Geographically?

North America was the largest region in the personalized cancer vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Personalized Cancer Vaccines Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/personalized-cancer-vaccines-global-market-report

Browse Through More Reports Similar to the Global Personalized Cancer Vaccines Market 2026, By The Business Research Company

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Cervical Cancer Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/cervical-cancer-vaccine-global-market-report

Dendritic Cell Cancer Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/dendritic-cell-cancer-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795